drugset / Trial / NCT06577415
A Study of RAY1225 in Participants With Impaired Liver Function
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to assess how fast RAY1225 gets into the blood stream and how long it takes the body to remove it in participants with impaired liver function compared to healthy participants.
Timeline
- Start
- 2024-08-26
- Primary completion
- 2025-10-31
- Completion
- 2025-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RAY1225 | Unknown | 3 mg | Subcutaneous |
Indications
No indication recorded.